Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 9,091.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,091.62% |
DeFi Development (DFDV) | 2,231.7% |
WW International, Inc Common Stock (WW) | 2,218.32% |
Diginex Limited Ordinary Shares (DGNX) | 1,263.15% |
FiEE (FIEE) | 1,207.34% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 1,058.33% |
Oncology Institute (TOI) | 1,033.99% |
Abivax SA American Depositary Shares (ABVX) | 969.89% |
Newegg Commerce (NEGG) | 962.5% |
Asset Entities Inc Class B Common Stock (ASST) | 860% |
Global Interactive Technologies (GITS) | 846.06% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 834.03% |
ThredUp (TDUP) | 738.89% |
SRM Entertainment, Inc Common Stock (SRM) | 690.32% |
Kindly (NAKA) | 639.52% |
mF International Limited Ordinary Shares (MFI) | 573.8% |
Immunoprecise Antibodies (IPA) | 573.17% |
Dominari (DOMH) | 560.51% |
Abits (ABTS) | 515.77% |
Airnet Technology (ANTE) | 475.19% |
I-Mab (IMAB) | 467.06% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 454.02% |
So-Young International (SY) | 414.62% |
ABVC BioPharma (ABVC) | 396.61% |
Verb Technology (VERB) | 386.4% |
